cell microarray assay Search Results


94
KCAS Bioanalytical and Biomarker Services biomarkers limonene
Biomarkers Limonene, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biomarkers limonene/product/KCAS Bioanalytical and Biomarker Services
Average 94 stars, based on 1 article reviews
biomarkers limonene - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
KCAS Bioanalytical and Biomarker Services hybrid immunocapture lc ms ms
Hybrid Immunocapture Lc Ms Ms, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hybrid immunocapture lc ms ms/product/KCAS Bioanalytical and Biomarker Services
Average 93 stars, based on 1 article reviews
hybrid immunocapture lc ms ms - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

99
KCAS Bioanalytical and Biomarker Services kcas bio analytical
Kcas Bio Analytical, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kcas bio analytical/product/KCAS Bioanalytical and Biomarker Services
Average 99 stars, based on 1 article reviews
kcas bio analytical - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

90
Verlag GmbH nanomolar synthesis in droplet microarrays with uv-triggered on-chip cell screening
Nanomolar Synthesis In Droplet Microarrays With Uv Triggered On Chip Cell Screening, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nanomolar synthesis in droplet microarrays with uv-triggered on-chip cell screening/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
nanomolar synthesis in droplet microarrays with uv-triggered on-chip cell screening - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
SuperArray Bioscience Corporation mouse oligo gearray osteogenesis microarrays
Mouse Oligo Gearray Osteogenesis Microarrays, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse oligo gearray osteogenesis microarrays/product/SuperArray Bioscience Corporation
Average 90 stars, based on 1 article reviews
mouse oligo gearray osteogenesis microarrays - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Broad Institute Inc functional analysis of the 20-cell microarray database
Functional Analysis Of The 20 Cell Microarray Database, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/functional analysis of the 20-cell microarray database/product/Broad Institute Inc
Average 90 stars, based on 1 article reviews
functional analysis of the 20-cell microarray database - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
SuperArray Bioscience Corporation gearray cell-cycle apoptosis pathway-specific microarrays
Gearray Cell Cycle Apoptosis Pathway Specific Microarrays, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gearray cell-cycle apoptosis pathway-specific microarrays/product/SuperArray Bioscience Corporation
Average 90 stars, based on 1 article reviews
gearray cell-cycle apoptosis pathway-specific microarrays - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Charles River Laboratories cell microarray
Retrogenix <t>microarray</t> screen. Expression vectors encoding >6000 human membrane proteins were arrayed on slides and overlaid with HEK293 cells for reverse transfection. AAV was added and cell-bound capsids were detected with an anti-AAV9 antibody. Bottom panel: Image from microarray screen demonstrating detection of virus spotted in gelatin (positive control) and VCAP-101 bound to cells expressing ALPL. b , Human ORFeome screen protocol. A lentiviral library containing 17,000 human ORFs was used to generate a stable HEK293T pool that was subjected to iterative rounds of transduction with VCAP-102-EGFP followed by sorting of GFP(+) cells. AAV9-mCherry was added to the third round of screening to identify EGFP(+)/mCherry(-) cells expressing a VCAP-102-specific receptor. Bottom panel: FACS gating strategy showing stepwise enrichment of permissive GFP(+) cells. c, Detection of ALPL by immunohistochemistry (IHC) in brain sections from human, African green monkey and mouse . d , Impact of ALPL depletion on VCAP-102 transduction. HeLa cells were transfected with siRNAs against ALPL and transduced with AAV9 or VCAP-102 containing a luciferase transgene. Luciferase data was normalized to VCAP-102 control siRNA (mean ± SD, n=3). e , Removal of cell surface GPI-AP proteins reduces VCAP-102 transduction. HeLa cells were treated with PI-PLC and transduced with AAV9 or VCAP-102 containing a luciferase transgene. Luciferase data (mean ± SD, n=3) is normalized to untreated controls. f , Plasma membrane localization of ALPL is necessary for VCAP-102 transduction. HEK293T cells were transfected with plasmid encoding an ALPL isoform defective for plasma membrane trafficking (ALPL-V2) and transduced with AAV9 or VCAP-102 encoding luciferase. 24h post-transduction a luciferase assay was performed. Data (mean ± SD, n=3) was normalized to vector control.
Cell Microarray, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell microarray/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
cell microarray - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
SuperArray Bioscience Corporation oligo gearray human neurogenesis and neural stem cell microarray
Retrogenix <t>microarray</t> screen. Expression vectors encoding >6000 human membrane proteins were arrayed on slides and overlaid with HEK293 cells for reverse transfection. AAV was added and cell-bound capsids were detected with an anti-AAV9 antibody. Bottom panel: Image from microarray screen demonstrating detection of virus spotted in gelatin (positive control) and VCAP-101 bound to cells expressing ALPL. b , Human ORFeome screen protocol. A lentiviral library containing 17,000 human ORFs was used to generate a stable HEK293T pool that was subjected to iterative rounds of transduction with VCAP-102-EGFP followed by sorting of GFP(+) cells. AAV9-mCherry was added to the third round of screening to identify EGFP(+)/mCherry(-) cells expressing a VCAP-102-specific receptor. Bottom panel: FACS gating strategy showing stepwise enrichment of permissive GFP(+) cells. c, Detection of ALPL by immunohistochemistry (IHC) in brain sections from human, African green monkey and mouse . d , Impact of ALPL depletion on VCAP-102 transduction. HeLa cells were transfected with siRNAs against ALPL and transduced with AAV9 or VCAP-102 containing a luciferase transgene. Luciferase data was normalized to VCAP-102 control siRNA (mean ± SD, n=3). e , Removal of cell surface GPI-AP proteins reduces VCAP-102 transduction. HeLa cells were treated with PI-PLC and transduced with AAV9 or VCAP-102 containing a luciferase transgene. Luciferase data (mean ± SD, n=3) is normalized to untreated controls. f , Plasma membrane localization of ALPL is necessary for VCAP-102 transduction. HEK293T cells were transfected with plasmid encoding an ALPL isoform defective for plasma membrane trafficking (ALPL-V2) and transduced with AAV9 or VCAP-102 encoding luciferase. 24h post-transduction a luciferase assay was performed. Data (mean ± SD, n=3) was normalized to vector control.
Oligo Gearray Human Neurogenesis And Neural Stem Cell Microarray, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oligo gearray human neurogenesis and neural stem cell microarray/product/SuperArray Bioscience Corporation
Average 90 stars, based on 1 article reviews
oligo gearray human neurogenesis and neural stem cell microarray - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Charles River Laboratories retrogenix™ cell microarray
Retrogenix <t>microarray</t> screen. Expression vectors encoding >6000 human membrane proteins were arrayed on slides and overlaid with HEK293 cells for reverse transfection. AAV was added and cell-bound capsids were detected with an anti-AAV9 antibody. Bottom panel: Image from microarray screen demonstrating detection of virus spotted in gelatin (positive control) and VCAP-101 bound to cells expressing ALPL. b , Human ORFeome screen protocol. A lentiviral library containing 17,000 human ORFs was used to generate a stable HEK293T pool that was subjected to iterative rounds of transduction with VCAP-102-EGFP followed by sorting of GFP(+) cells. AAV9-mCherry was added to the third round of screening to identify EGFP(+)/mCherry(-) cells expressing a VCAP-102-specific receptor. Bottom panel: FACS gating strategy showing stepwise enrichment of permissive GFP(+) cells. c, Detection of ALPL by immunohistochemistry (IHC) in brain sections from human, African green monkey and mouse . d , Impact of ALPL depletion on VCAP-102 transduction. HeLa cells were transfected with siRNAs against ALPL and transduced with AAV9 or VCAP-102 containing a luciferase transgene. Luciferase data was normalized to VCAP-102 control siRNA (mean ± SD, n=3). e , Removal of cell surface GPI-AP proteins reduces VCAP-102 transduction. HeLa cells were treated with PI-PLC and transduced with AAV9 or VCAP-102 containing a luciferase transgene. Luciferase data (mean ± SD, n=3) is normalized to untreated controls. f , Plasma membrane localization of ALPL is necessary for VCAP-102 transduction. HEK293T cells were transfected with plasmid encoding an ALPL isoform defective for plasma membrane trafficking (ALPL-V2) and transduced with AAV9 or VCAP-102 encoding luciferase. 24h post-transduction a luciferase assay was performed. Data (mean ± SD, n=3) was normalized to vector control.
Retrogenix™ Cell Microarray, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/retrogenix™ cell microarray/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
retrogenix™ cell microarray - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Starlight Co Ltd cell microarray chip
(A) Human leukocytes/carcinoma cells are dispersed on a cell <t>microarray</t> chip, followed by 15 minutes' standing to allow the cells to settle down into the microchambers, and are then stained with fluorescence-labeled antibodies against carcinoma cells. (B) Fluorescence-positive CTCs are detected by using a microarray scanner with a confocal fluorescence laser. (C) The target CTCs are analyzed quantitatively at the single-cell level.
Cell Microarray Chip, supplied by Starlight Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell microarray chip/product/Starlight Co Ltd
Average 90 stars, based on 1 article reviews
cell microarray chip - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
SuperArray Bioscience Corporation microarrays containing representative genes associated with pathways specific for apoptosis or cell proliferation
(A) Human leukocytes/carcinoma cells are dispersed on a cell <t>microarray</t> chip, followed by 15 minutes' standing to allow the cells to settle down into the microchambers, and are then stained with fluorescence-labeled antibodies against carcinoma cells. (B) Fluorescence-positive CTCs are detected by using a microarray scanner with a confocal fluorescence laser. (C) The target CTCs are analyzed quantitatively at the single-cell level.
Microarrays Containing Representative Genes Associated With Pathways Specific For Apoptosis Or Cell Proliferation, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarrays containing representative genes associated with pathways specific for apoptosis or cell proliferation/product/SuperArray Bioscience Corporation
Average 90 stars, based on 1 article reviews
microarrays containing representative genes associated with pathways specific for apoptosis or cell proliferation - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Retrogenix microarray screen. Expression vectors encoding >6000 human membrane proteins were arrayed on slides and overlaid with HEK293 cells for reverse transfection. AAV was added and cell-bound capsids were detected with an anti-AAV9 antibody. Bottom panel: Image from microarray screen demonstrating detection of virus spotted in gelatin (positive control) and VCAP-101 bound to cells expressing ALPL. b , Human ORFeome screen protocol. A lentiviral library containing 17,000 human ORFs was used to generate a stable HEK293T pool that was subjected to iterative rounds of transduction with VCAP-102-EGFP followed by sorting of GFP(+) cells. AAV9-mCherry was added to the third round of screening to identify EGFP(+)/mCherry(-) cells expressing a VCAP-102-specific receptor. Bottom panel: FACS gating strategy showing stepwise enrichment of permissive GFP(+) cells. c, Detection of ALPL by immunohistochemistry (IHC) in brain sections from human, African green monkey and mouse . d , Impact of ALPL depletion on VCAP-102 transduction. HeLa cells were transfected with siRNAs against ALPL and transduced with AAV9 or VCAP-102 containing a luciferase transgene. Luciferase data was normalized to VCAP-102 control siRNA (mean ± SD, n=3). e , Removal of cell surface GPI-AP proteins reduces VCAP-102 transduction. HeLa cells were treated with PI-PLC and transduced with AAV9 or VCAP-102 containing a luciferase transgene. Luciferase data (mean ± SD, n=3) is normalized to untreated controls. f , Plasma membrane localization of ALPL is necessary for VCAP-102 transduction. HEK293T cells were transfected with plasmid encoding an ALPL isoform defective for plasma membrane trafficking (ALPL-V2) and transduced with AAV9 or VCAP-102 encoding luciferase. 24h post-transduction a luciferase assay was performed. Data (mean ± SD, n=3) was normalized to vector control.

Journal: bioRxiv

Article Title: Highly conserved brain vascular receptor ALPL mediates transport of engineered viral vectors across the blood-brain barrier

doi: 10.1101/2024.03.12.584703

Figure Lengend Snippet: Retrogenix microarray screen. Expression vectors encoding >6000 human membrane proteins were arrayed on slides and overlaid with HEK293 cells for reverse transfection. AAV was added and cell-bound capsids were detected with an anti-AAV9 antibody. Bottom panel: Image from microarray screen demonstrating detection of virus spotted in gelatin (positive control) and VCAP-101 bound to cells expressing ALPL. b , Human ORFeome screen protocol. A lentiviral library containing 17,000 human ORFs was used to generate a stable HEK293T pool that was subjected to iterative rounds of transduction with VCAP-102-EGFP followed by sorting of GFP(+) cells. AAV9-mCherry was added to the third round of screening to identify EGFP(+)/mCherry(-) cells expressing a VCAP-102-specific receptor. Bottom panel: FACS gating strategy showing stepwise enrichment of permissive GFP(+) cells. c, Detection of ALPL by immunohistochemistry (IHC) in brain sections from human, African green monkey and mouse . d , Impact of ALPL depletion on VCAP-102 transduction. HeLa cells were transfected with siRNAs against ALPL and transduced with AAV9 or VCAP-102 containing a luciferase transgene. Luciferase data was normalized to VCAP-102 control siRNA (mean ± SD, n=3). e , Removal of cell surface GPI-AP proteins reduces VCAP-102 transduction. HeLa cells were treated with PI-PLC and transduced with AAV9 or VCAP-102 containing a luciferase transgene. Luciferase data (mean ± SD, n=3) is normalized to untreated controls. f , Plasma membrane localization of ALPL is necessary for VCAP-102 transduction. HEK293T cells were transfected with plasmid encoding an ALPL isoform defective for plasma membrane trafficking (ALPL-V2) and transduced with AAV9 or VCAP-102 encoding luciferase. 24h post-transduction a luciferase assay was performed. Data (mean ± SD, n=3) was normalized to vector control.

Article Snippet: The Retrogenix cell microarray was performed by Charles River Laboratories. cDNA expression vectors encoding over 6000 human membrane proteins, secreted or cell surface tethered-secreted proteins were arrayed across a series of slides in duplicate and overlaid with HEK293 as previously described .

Techniques: Microarray, Expressing, Membrane, Transfection, Virus, Positive Control, Transduction, Immunohistochemistry, Luciferase, Plasmid Preparation

(A) Human leukocytes/carcinoma cells are dispersed on a cell microarray chip, followed by 15 minutes' standing to allow the cells to settle down into the microchambers, and are then stained with fluorescence-labeled antibodies against carcinoma cells. (B) Fluorescence-positive CTCs are detected by using a microarray scanner with a confocal fluorescence laser. (C) The target CTCs are analyzed quantitatively at the single-cell level.

Journal: PLoS ONE

Article Title: Accurate Detection of Carcinoma Cells by Use of a Cell Microarray Chip

doi: 10.1371/journal.pone.0032370

Figure Lengend Snippet: (A) Human leukocytes/carcinoma cells are dispersed on a cell microarray chip, followed by 15 minutes' standing to allow the cells to settle down into the microchambers, and are then stained with fluorescence-labeled antibodies against carcinoma cells. (B) Fluorescence-positive CTCs are detected by using a microarray scanner with a confocal fluorescence laser. (C) The target CTCs are analyzed quantitatively at the single-cell level.

Article Snippet: As shown in , the cell microarray chip comprised 20,944 microchambers (105-μm upper diameter, 68-μm lower diameter, 50-μm depth, and spacing as indicated) and was made from polystyrene by the Lithographic Galvanoformung Abformung process by Starlight Co. Ltd. (Osaka, Japan) .

Techniques: Microarray, Staining, Fluorescence, Labeling

(A) Photo of an actual cell microarray chip. (B, C) SEM images of a cell microarray chip. The cell microarray chip comprises 20,944 microchambers in a plastic slide on a glass slide. The cell microarray chip has 112 (14×8) clusters, each having 187 microchambers. (D) Each microchamber is 105 µm in upper diameter, 50 µm in depth, and has the shape of a frustum with a 68-µm diameter flat bottom for the accommodation of leukocytes as a monolayer.

Journal: PLoS ONE

Article Title: Accurate Detection of Carcinoma Cells by Use of a Cell Microarray Chip

doi: 10.1371/journal.pone.0032370

Figure Lengend Snippet: (A) Photo of an actual cell microarray chip. (B, C) SEM images of a cell microarray chip. The cell microarray chip comprises 20,944 microchambers in a plastic slide on a glass slide. The cell microarray chip has 112 (14×8) clusters, each having 187 microchambers. (D) Each microchamber is 105 µm in upper diameter, 50 µm in depth, and has the shape of a frustum with a 68-µm diameter flat bottom for the accommodation of leukocytes as a monolayer.

Article Snippet: As shown in , the cell microarray chip comprised 20,944 microchambers (105-μm upper diameter, 68-μm lower diameter, 50-μm depth, and spacing as indicated) and was made from polystyrene by the Lithographic Galvanoformung Abformung process by Starlight Co. Ltd. (Osaka, Japan) .

Techniques: Microarray

(A, B) Photographic light microscopic images of T lymphoblastoid leukemia cells incubated on a cell microarray chip before (A) and after (B) washing of the chip surface. (C–F) Photos of microchamber appearance after washing when T lymphoblastoid leukemia suspensions of 2.5×10 6 (C), 5.0×10 6 (D), 7.5×10 6 (E) or 1.0×10 7 (F) cells/ml were applied to the microarray chip. Concentrations of 7.5×10 6 cells/ml of T lymphoblastoid leukemia and above afforded tight confinement and formation of a monolayer in the microchambers. (Bar: 20 µm).

Journal: PLoS ONE

Article Title: Accurate Detection of Carcinoma Cells by Use of a Cell Microarray Chip

doi: 10.1371/journal.pone.0032370

Figure Lengend Snippet: (A, B) Photographic light microscopic images of T lymphoblastoid leukemia cells incubated on a cell microarray chip before (A) and after (B) washing of the chip surface. (C–F) Photos of microchamber appearance after washing when T lymphoblastoid leukemia suspensions of 2.5×10 6 (C), 5.0×10 6 (D), 7.5×10 6 (E) or 1.0×10 7 (F) cells/ml were applied to the microarray chip. Concentrations of 7.5×10 6 cells/ml of T lymphoblastoid leukemia and above afforded tight confinement and formation of a monolayer in the microchambers. (Bar: 20 µm).

Article Snippet: As shown in , the cell microarray chip comprised 20,944 microchambers (105-μm upper diameter, 68-μm lower diameter, 50-μm depth, and spacing as indicated) and was made from polystyrene by the Lithographic Galvanoformung Abformung process by Starlight Co. Ltd. (Osaka, Japan) .

Techniques: Incubation, Microarray

(A, B) Photographic light microscopic images of carcinoma cells on a cell microarray chip before (A) and after (B) washing of the chip surface. (C) Carcinoma cells showed tight confinement and had formed a monolayer in the microchamber when a concentration of 7.5×10 6 cells/ml was used. (Bar: 20 µm).

Journal: PLoS ONE

Article Title: Accurate Detection of Carcinoma Cells by Use of a Cell Microarray Chip

doi: 10.1371/journal.pone.0032370

Figure Lengend Snippet: (A, B) Photographic light microscopic images of carcinoma cells on a cell microarray chip before (A) and after (B) washing of the chip surface. (C) Carcinoma cells showed tight confinement and had formed a monolayer in the microchamber when a concentration of 7.5×10 6 cells/ml was used. (Bar: 20 µm).

Article Snippet: As shown in , the cell microarray chip comprised 20,944 microchambers (105-μm upper diameter, 68-μm lower diameter, 50-μm depth, and spacing as indicated) and was made from polystyrene by the Lithographic Galvanoformung Abformung process by Starlight Co. Ltd. (Osaka, Japan) .

Techniques: Microarray, Concentration Assay

(A, B) Photographic light microscopic images of leukocytes on a cell microarray chip before (A) and after (B) washing of the chip surface. (C) The leukocytes showed tight confinement and had formed a monolayer in the microchamber. (Bar: 20 µm).

Journal: PLoS ONE

Article Title: Accurate Detection of Carcinoma Cells by Use of a Cell Microarray Chip

doi: 10.1371/journal.pone.0032370

Figure Lengend Snippet: (A, B) Photographic light microscopic images of leukocytes on a cell microarray chip before (A) and after (B) washing of the chip surface. (C) The leukocytes showed tight confinement and had formed a monolayer in the microchamber. (Bar: 20 µm).

Article Snippet: As shown in , the cell microarray chip comprised 20,944 microchambers (105-μm upper diameter, 68-μm lower diameter, 50-μm depth, and spacing as indicated) and was made from polystyrene by the Lithographic Galvanoformung Abformung process by Starlight Co. Ltd. (Osaka, Japan) .

Techniques: Microarray

(A–I) Scanned images of leukocytes/carcinoma cells on a cell microarray chip obtained with the microarray scanner. (A) Negative control (no carcinoma cells). (B, D, G) Carcinoma cells (0.01, 0.001, and 0.0001%) were scanned in 3, 9, and 64 clusters, respectively, on the cell microarray chip. (C, E, F, H, I) Magnified views of the boxed regions. Color scale represents the intensity of fluorescent emission.

Journal: PLoS ONE

Article Title: Accurate Detection of Carcinoma Cells by Use of a Cell Microarray Chip

doi: 10.1371/journal.pone.0032370

Figure Lengend Snippet: (A–I) Scanned images of leukocytes/carcinoma cells on a cell microarray chip obtained with the microarray scanner. (A) Negative control (no carcinoma cells). (B, D, G) Carcinoma cells (0.01, 0.001, and 0.0001%) were scanned in 3, 9, and 64 clusters, respectively, on the cell microarray chip. (C, E, F, H, I) Magnified views of the boxed regions. Color scale represents the intensity of fluorescent emission.

Article Snippet: As shown in , the cell microarray chip comprised 20,944 microchambers (105-μm upper diameter, 68-μm lower diameter, 50-μm depth, and spacing as indicated) and was made from polystyrene by the Lithographic Galvanoformung Abformung process by Starlight Co. Ltd. (Osaka, Japan) .

Techniques: Microarray, Negative Control

(A) Scanned images of cells on a cell microarray chip, obtained with the microarray scanner. The cells were immunostained with PE-labeled anti-cytokeratin monoclonal antibody. (B) Magnified view of the boxed region. Color scale represents the intensity of fluorescent emission.

Journal: PLoS ONE

Article Title: Accurate Detection of Carcinoma Cells by Use of a Cell Microarray Chip

doi: 10.1371/journal.pone.0032370

Figure Lengend Snippet: (A) Scanned images of cells on a cell microarray chip, obtained with the microarray scanner. The cells were immunostained with PE-labeled anti-cytokeratin monoclonal antibody. (B) Magnified view of the boxed region. Color scale represents the intensity of fluorescent emission.

Article Snippet: As shown in , the cell microarray chip comprised 20,944 microchambers (105-μm upper diameter, 68-μm lower diameter, 50-μm depth, and spacing as indicated) and was made from polystyrene by the Lithographic Galvanoformung Abformung process by Starlight Co. Ltd. (Osaka, Japan) .

Techniques: Microarray, Labeling

Analysis of spiked carcinoma cells in human whole blood on a  cell microarray chip.

Journal: PLoS ONE

Article Title: Accurate Detection of Carcinoma Cells by Use of a Cell Microarray Chip

doi: 10.1371/journal.pone.0032370

Figure Lengend Snippet: Analysis of spiked carcinoma cells in human whole blood on a cell microarray chip.

Article Snippet: As shown in , the cell microarray chip comprised 20,944 microchambers (105-μm upper diameter, 68-μm lower diameter, 50-μm depth, and spacing as indicated) and was made from polystyrene by the Lithographic Galvanoformung Abformung process by Starlight Co. Ltd. (Osaka, Japan) .

Techniques: Microarray

(A–L) Cultured T lymphoblastoid leukemia (A–F) and leukocytes isolated from whole blood (F–L) were stained with PE-labeled anti-cytokeratin monoclonal antibody (A, G) and APC-labeled anti-EpCAM monoclonal antibody (C, I). (E, K) Merged images identify doubly-positive carcinoma cells in each panel. Magnified views of the boxed regions (B, D, F, H, J, L). Scatter-plot analysis of 3 cluster areas representing 561 microchambers in a cell microarray chip .

Journal: PLoS ONE

Article Title: Accurate Detection of Carcinoma Cells by Use of a Cell Microarray Chip

doi: 10.1371/journal.pone.0032370

Figure Lengend Snippet: (A–L) Cultured T lymphoblastoid leukemia (A–F) and leukocytes isolated from whole blood (F–L) were stained with PE-labeled anti-cytokeratin monoclonal antibody (A, G) and APC-labeled anti-EpCAM monoclonal antibody (C, I). (E, K) Merged images identify doubly-positive carcinoma cells in each panel. Magnified views of the boxed regions (B, D, F, H, J, L). Scatter-plot analysis of 3 cluster areas representing 561 microchambers in a cell microarray chip .

Article Snippet: As shown in , the cell microarray chip comprised 20,944 microchambers (105-μm upper diameter, 68-μm lower diameter, 50-μm depth, and spacing as indicated) and was made from polystyrene by the Lithographic Galvanoformung Abformung process by Starlight Co. Ltd. (Osaka, Japan) .

Techniques: Cell Culture, Isolation, Staining, Labeling, Microarray